Atlas Trials

Application and Exploration of Personalized ctDNA-MRD Detection Technology in Predicting the Efficacy of Neoadjuvant Therapy for Rectal Cancer

Clinical trial NCT07393048 · RECRUITING

Trial details

NCT number
NCT07393048
Sponsor
Beijing Friendship Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Locally Advanced Rectal Cancer (LARC)
Start date
2026-02-15
Primary completion
2028-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.